Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
Public ClinicalTrials.gov record NCT02537574. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL®
Study identification
- NCT ID
- NCT02537574
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Alkermes, Inc.
- Industry
- Enrollment
- 380 participants
Conditions and interventions
Conditions
Interventions
- NTX/BUP Drug
- NTX/PBO-B Drug
- PBO-N/PBO-B Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2015
- Primary completion
- Oct 26, 2016
- Completion
- Jan 8, 2017
- Last update posted
- Mar 5, 2019
2015 – 2017
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Country Clinical Research | Oceanside | California | 92056 | — |
| NRC Research Institute | Orange | California | 92868 | — |
| Atlantic Shores Hospital | Lauderhill | Florida | 33308 | — |
| TRY Research | Maitland | Florida | 84107 | — |
| Research Centers of America | Oakland Park | Florida | 33334 | — |
| CNS Healthcare | Orlando | Florida | 32801 | — |
| Neuroscience Research Institute | Winfield | Illinois | 60190 | — |
| John Hopkins University School of Medicine | Baltimore | Maryland | 21224 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| PRA Health Sciences | Marlton | New Jersey | 08053 | — |
| New York State Psychiatric Institute/ Columbia University | New York | New York | 10032 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Neuro-Behavioral Clinical Research, Inc. | Canton | Ohio | 44718 | — |
| Midwest Clinical Research Center, LLC | Dayton | Ohio | 45417 | — |
| University Of Pennsylvania - Treatment Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Western Psychiatric Institute and Clinic of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Community Clinical Research, Inc. | Austin | Texas | 78754 | — |
| Insite Clinical Research | DeSoto | Texas | 75115 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Pharmaceutical Research Associates Inc. | Salt Lake City | Utah | 32751 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02537574, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02537574 live on ClinicalTrials.gov.